Phthalate-Induced Liver Protection against Deleterious Effects of the Th1 Response: A Potentially Serious Health Hazard

Mostafa Z. Badr(University of Missouri–Kansas City), Agostino Molteni(University of Missouri–Kansas City), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Betty Herndon(University of Missouri–Kansas City), Alexander Shnyra(Kansas City University), Mikhail N. Zoubine(University of Missouri–Kansas City), Maxim Norkin(Centre Hospitalier Universitaire Vaudois), Tim Quinn(University of Missouri–Kansas City), Michael L. Cunningham(Seattle Children's Hospital)
PPAR Research
January 1, 2007
10.1155/2007/49671
Cited by 5

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|Journal of Clinical Oncology|2015|418
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396